share_log

What 7 Analyst Ratings Have To Say About Health Catalyst

Benzinga ·  Apr 10 11:00

7 analysts have shared their evaluations of Health Catalyst (NASDAQ:HCAT) during the recent three months, expressing a mix of bullish and bearish perspectives.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings25000
Last 30D01000
1M Ago00000
2M Ago14000
3M Ago10000

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $13.14, a high estimate of $16.00, and a low estimate of $10.00. This current average reflects an increase of 1.08% from the previous average price target of $13.00.

price target chart

Decoding Analyst Ratings: A Detailed Look

A clear picture of Health Catalyst's perception...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment